The Glaring Gap in Healthcare: Why Ozempic's Price Tag Is a Bigger Issue Than You Think The billion dollar GLP 1 medication conundrum has been making headlines lately, but beneath the surface lies a more complex and far reaching problem.
It's not just about whether these medications are worth their hefty price tag; it's about how we value healthcare in this country.
Researchers at the University of Mississippi have studied the financial implications of GLP 1 coverage and found that even if these medications provide tremendous value to society, they could still overwhelm insurance budgets.